Search - tctmd.com

Displaying 861 - 880 of 1642

Sort: Relevancy | Date

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

Taking the Reins on Systems of Care for STEMI Patients - AHA Mission: Lifeline Program

Presentation

Taking the Reins on Systems of Care for STEMI Patients - AHA Mission: Lifeline Program

May 01, 2018

EMS Going Directly to PCI Centers Speeds Up STEMI Treatment

News Daily News

EMS Going Directly to PCI Centers Speeds Up STEMI Treatment

May 01, 2018

Supplemental Oxygen Not Beneficial in MI Patients With Normal O2 Levels: Meta-analysis

News Daily News

Supplemental Oxygen Not Beneficial in MI Patients With Normal O2 Levels: Meta-analysis

Michael O'Riordan

April 11, 2018

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

News Daily News

FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests

April 11, 2018

Skyrocketing Costs of CVD Will Be Amplified by Informal Caregiving: AHA

News Daily News

Skyrocketing Costs of CVD Will Be Amplified by Informal Caregiving: AHA

April 09, 2018

Physical Activity Conversations With Patients Need to Be Routine, AHA Says

News Daily News

Physical Activity Conversations With Patients Need to Be Routine, AHA Says

April 06, 2018

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

News Daily News

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Michael O'Riordan

April 05, 2018

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

News Conference News ACC 2018

Salt in the Wound: Experts Clash Over Ideal Sodium Targets in Hypertension

Michael O'Riordan

March 15, 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

TCTMD’s Top 10 Most Popular Stories for February 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2018

March 01, 2018

‘High Index of Suspicion’ First Step in Successful Management of SCAD

News Daily News

‘High Index of Suspicion’ First Step in Successful Management of SCAD

Michael O'Riordan

February 27, 2018

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

News Features

Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks?

February 26, 2018

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

News Daily News

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Michael O'Riordan

February 02, 2018

AHA Releases Scientific Statement on Breast Cancer and CVD

News Daily News

AHA Releases Scientific Statement on Breast Cancer and CVD

February 01, 2018

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

News Daily News

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

January 22, 2018

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

News Daily News

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Michael O'Riordan

January 02, 2018

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

December 26, 2017

AAFP Says It Cannot Endorse New Hypertension Guideline

News Daily News

AAFP Says It Cannot Endorse New Hypertension Guideline

December 18, 2017

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

News Daily News

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

December 04, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.